Rep. Josh Gottheimer sold Sarepta Therapeutics (SRPT)
Rep. Josh Gottheimer (D-NJ-5) · $1K–$15K · traded Jun 13, 2023
- Transaction
- Sold
- Amount
- $1K–$15K
- Owner
- Joint
- Traded
- Jun 13, 2023
- Disclosed
- Jul 11, 2023
- Days to disclose
- 28
- Asset type
- Stock
- As filed
- Sarepta Therapeutics, Inc.
- Industry
- Biotechnology · Healthcare
Other trades in this filing
All of Gottheimer's trades →- Jul 11, 2023$1K–$15K
$1K–$15K · Traded Jun 26, 2023 · disclosed Jul 11, 2023 · Joint
Got $4K from the company’s PAC - Jul 11, 2023$1K–$15K
$1K–$15K · Traded Jun 26, 2023 · disclosed Jul 11, 2023 · Joint
- Jul 11, 2023$1K–$15K
$1K–$15K · Traded Jun 26, 2023 · disclosed Jul 11, 2023 · Joint
- Jul 11, 2023$1K–$15K
$1K–$15K · Traded Jun 26, 2023 · disclosed Jul 11, 2023 · Joint
- Jul 11, 2023$1K–$15K
$1K–$15K · Traded Jun 26, 2023 · disclosed Jul 11, 2023 · Joint
- Jul 11, 2023$1K–$15K
$1K–$15K · Traded Jun 26, 2023 · disclosed Jul 11, 2023 · Joint
- Jul 11, 2023$1K–$15K
Sold (partial) United Parcel Service UPS
$1K–$15K · Traded Jun 26, 2023 · disclosed Jul 11, 2023 · Joint
Got $10K from the company’s PAC - Jul 11, 2023$1K–$15K
$1K–$15K · Traded Jun 26, 2023 · disclosed Jul 11, 2023 · Joint
- Jul 11, 2023$1K–$15K
Sold (partial) Regeneron Pharmaceuticals REGN
$1K–$15K · Traded Jun 22, 2023 · disclosed Jul 11, 2023 · Joint
- Jul 11, 2023$1K–$15K
$1K–$15K · Traded Jun 22, 2023 · disclosed Jul 11, 2023 · Joint
- Jul 11, 2023$1K–$15K
$1K–$15K · Traded Jun 22, 2023 · disclosed Jul 11, 2023 · Joint
- Jul 11, 2023$1K–$15K
$1K–$15K · Traded Jun 22, 2023 · disclosed Jul 11, 2023 · Joint
- Jul 11, 2023$1K–$15K
Sold (partial) Lowe's Companies LOW
$1K–$15K · Traded Jun 22, 2023 · disclosed Jul 11, 2023 · Joint
- Jul 11, 2023$1K–$15K
$1K–$15K · Traded Jun 22, 2023 · disclosed Jul 11, 2023 · Joint
- Jul 11, 2023$1K–$15K
$1K–$15K · Traded Jun 22, 2023 · disclosed Jul 11, 2023 · Joint
- Jul 11, 2023$1K–$15K
$1K–$15K · Traded Jun 22, 2023 · disclosed Jul 11, 2023 · Joint
- Jul 11, 2023$1K–$15K
$1K–$15K · Traded Jun 22, 2023 · disclosed Jul 11, 2023 · Joint
- Jul 11, 2023$1K–$15K
Sold (partial) Rockwell Automation ROK
$1K–$15K · Traded Jun 22, 2023 · disclosed Jul 11, 2023 · Joint
- Jul 11, 2023$1K–$15K
$1K–$15K · Traded Jun 22, 2023 · disclosed Jul 11, 2023 · Joint
- Jul 11, 2023$1K–$15K
Sold (partial) Advanced Micro Devices AMD
$1K–$15K · Traded Jun 22, 2023 · disclosed Jul 11, 2023 · Joint
Recent Congress trades in SRPT
- May 6, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Sold Sarepta Therapeutics SRPT
$1K–$15K · Traded Apr 14, 2025 · disclosed May 6, 2025
- Aug 21, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Bought Sarepta Therapeutics SRPT
$1K–$15K · Traded Jul 14, 2023 · disclosed Aug 21, 2023 · Joint
- May 19, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
Sold Sarepta Therapeutics SRPT
$15K–$50K · Traded Apr 10, 2023 · disclosed May 19, 2023
- Apr 20, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Bought Sarepta Therapeutics SRPT
$1K–$15K · Traded Mar 6, 2023 · disclosed Apr 20, 2023 · Joint
- Apr 17, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
Bought Sarepta Therapeutics SRPT
$15K–$50K · Traded Mar 6, 2023 · disclosed Apr 17, 2023
- Feb 24, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
Sold Sarepta Therapeutics SRPT
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
Company context for SRPT
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
SRPT: third_quarter 2026 lobbying report
H.R. 9260 - LHHS Appropriations Rare Pediatric Disease Priority Review Voucher (PRV) Program Issues related to patient access to treatment National Security Commission on emerging biotechnology policy proposals Issues related to Section 232
Public: Oct 19, 2026, 4:58 PM EDTOriginal source ↗SRPT: second_quarter 2026 lobbying report
H.R. 9260 - LHHS Appropriations H.R. 1509 - Accelerating Kids Access to Care Act Patient Access Act Issues related to patient access to treatment National Security Commission on emerging biotechnology policy proposals Issues related to supply chain Issues related to Section 232
Public: Jul 20, 2026, 1:40 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.